ContractAccession Agreement • March 17th, 2022 • Dievini Hopp BioTech Holding GmbH & Co KG • Pharmaceutical preparations
Information identifying certain issuers has been excluded from this exhibit because it is both not material and is the type that the Reporting Persons treat as private or confidential.
JOINT FILING STATEMENTJoint Filing Agreement • March 17th, 2022 • Dievini Hopp BioTech Holding GmbH & Co KG • Pharmaceutical preparations
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common shares of CureVac N.V. and further agree that this Joint Filing Agreement be included as an exhibit to such joint filing.
